Pharmafile Logo
Pharmafocus logo
Advanced Search

gout

Showing 10 posts of 10 posts found.

shutterstock_79370437

Ironwood returns US Zurampic rights to AstraZeneca, announces operational cuts

August 7, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Ironwood, Zurampic, gout, pharma

Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …

News

FDA approves Ironwood’s combination gout treatment

August 22, 2017
Manufacturing and Production, Sales and Marketing Duzallo, FDA, Ironwood Pharmaceuticals, gout, life sciences, pharma, pharmaceuticals

Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …

News
pills_spill

Potential treatment for opioid withdrawal discovered

February 1, 2017
Medical Communications, Research and Development University of Calgary, gout, opioid

Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …

News
astrazeneca_plaque

AstraZeneca licenses gout drug Zurampic to Grünenthal in Europe and Latin America

June 2, 2016
Business Services, Manufacturing and Production, Sales and Marketing AstraZeneca, Grunenthal, Licencing, Zurampic, gout, sales

UK drugmaker AstraZeneca (LSE: AZN) on Thursday said it has entered into a licensing agreement worth up to $230 million …

News
ironwood_pharma

AstraZeneca sells US rights for gout treatment to Ironwood Pharmaceuticals

April 27, 2016
Research and Development, Sales and Marketing AstraZeneca, Ironwood, Licencing, Zurampic, agreement, exclusive, gout, lesinurad, sales

AstraZeneca (LSE: AZN) has entered into a licencing agreement with Ironwood Pharmaceuticals (NASDAQ: IRWD) which will see the latter granted …

News
2000px-food_and_drug_administration_logo

FDA approves AstraZeneca’s gout drug Zurampic

December 23, 2015
Sales and Marketing AstraZeneca, FDA, Zurampic, gout, lensinurad

The US FDA has approved AstraZeneca’s Zurampic to treat high levels of uric acid in the blood. The drug is …

News
AZ sign

FDA backs AZ gout drug despite safety concerns

October 26, 2015
Sales and Marketing AstraZeneca, Zurampic, gout, lesinurad

FDA reviewers have recommended approving AstraZeneca’s new gout therapy Zurampic, which the company purchased in a $1.3 billion buyout, despite …

News
AstraZeneca picture

AstraZeneca to buy Ardea for $1.3 billion

April 23, 2012
Research and Development, Sales and Marketing Ardea, AstraZeneca, febuxostat, gout

AstraZeneca is to buy Ardea Biosciences for $1 billion to help bolster its pipeline. Under the terms of the agreement, …

News
takeda_tokyo_hq

Takeda to buy gout specialist URL Pharma for $800m

April 16, 2012
Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout

Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid.  …

News

Savient plays down gout drug manufacturing problems

January 11, 2011
Manufacturing and Production, Sales and Marketing Krystexxa, Savient, biologic manufacturing, gout, manufacturing compliance, pegloticase

Savient Pharmaceuticals has reported that some production batches of Krystexxa, its recently-approved second-line treatment for gout, have failed to meet …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024